Consensus bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 12:22:14 12/02/2026 GMT			5-day change	1st Jan Change
93.30 ^EUR	+0.38%		-4.31%	-15.41%

02-02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
01-22	Interparfums, Michelin, Société Générale, Ubisoft... Stocks to Watch Today in Paris

Evolution of the Average Target: bioMérieux

Evolution of the Target Price: bioMérieux

Changes in Analyst Recommendations: bioMérieux

6b0bd0.5bIaO2fWu2_K5B0Ny9y5xNeYd9gxEOspaCATYuuq1K0.hNsuAhaOyTiau3F_r7TUlq3IFpUBc4JtChZrOJHJgJ2X1WsMDK_eX6KzKQ~d194e1e4fbac0f20846d6ab3267d8d64

Analysts' recommendations: bioMérieux

02-02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
01-20	TP ICAP Midcap Upgrades bioMérieux to Buy	MT
11-10	UBS Maintains Buy Rating on BioMérieux, Confirms Price Target
11-05	Analysts Maintain Buy Ratings on bioMérieux After Q3 Results
11-05	Invest Securities Upgrades bioMérieux to Buy	MT
11-05	BioMérieux: Invest Securities upgrades stock after quarterly results
11-04	Biomérieux Q3 earnings miss prompts softer 2025 guidance
11-04	Stifel remains bullish on BioMérieux after trading update.
22/10/25	CIC Market Solutions Upgrades bioMérieux to Buy, Boosts PT	MT
11/09/25	BioMérieux: UBS Raises Price Target
11/09/25	BioMérieux: UBS raises target price
05/09/25	BioMérieux: Invest Securities Downgrades Rating to Neutral
05/09/25	BioMérieux: Invest Securities downgrades stock
05/09/25	Invest Securities Downgrades bioMérieux to Neutral, Lowers PT	MT
04/09/25	Gilbert Dupont Downgrades bioMérieux to Add	MT
04/09/25	BioMerieux: The H1 results are promising, confirming the attractiveness of market dynamics
04/09/25	BioMérieux: Oddo BHF confirms rating after new forecasts
04/09/25	BioMérieux: Stifel maintains buy rating
27/08/25	JPMorgan Initiates bioMérieux with Neutral Rating	MT
26/08/25	Morgan Stanley Downgrades bioMérieux to Equalweight, Trims PT	MT
15/07/25	AlphaValue/Baader Europe Ups BioMérieux Price Target	MT
14/07/25	BioMérieux: AlphaValue raises target price
11/07/25	BioMerieux: Attractiveness reinforced
07/05/25	RBC Capital Downgrades bioMérieux to Sector Perform, Trims PT	MT
07/05/25	BioMérieux: RBC downgrades stock

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BIOMÉRIEUX					+28.15%
	GUARDANT HEALTH, INC.					+16.41%
	CARIS LIFE SCIENCES, INC.					+76.23%
	SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.					+32.52%
	DIASORIN S.P.A.					+7.9%
	LANTHEUS HOLDINGS, INC.					+25.77%
	AUTOBIO DIAGNOSTICS CO., LTD.					+21.97%
	10X GENOMICS, INC.					-5.6%
	Average					+25.42%
	Weighted average by Cap.					+27.19%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

92.95EUR

Average target price

119.12EUR

Spread / Average Target

+28.15%

High Price Target

138.00EUR

Spread / Highest target

+48.47%

Low Price Target

100.00EUR

Spread / Lowest Target

+7.58%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

TP ICAP Midcap
Invest Securities
alphavalue	Anas Patel
CIC Market Solutions
Gilbert Dupont
JPMorgan
Morgan Stanley
RBC Capital Markets
AlphaValue/Baader Europe
ODDO BHF
UBS
Deutsche Bank Securities
Stifel Nicolaus
Berenberg Bank